NBIX stock news
This page provides real-time market news, earnings updates, and company announcements related to Neurocrine Biosciences, Inc. (NBIX).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-03-28 24:16 EST
Neurocrine: Fourth Quarter Earnings Overview
101 finance2026-02-11 21:21:09
New Strong Sell Stocks for February 18th
Finviz2026-02-18 10:21:36
Needham Bullish on Neurocrine Biosciences, Inc. (NBIX) Pipeline Amid 2026 Growth Expectations for Crenessity and Ingrezza
Finviz2026-02-19 02:36:45
Truist Lowers Neurocrine Biosciences, Inc.'s (NBIX) PT Following 2026 Outlook Update
Finviz2026-02-23 21:33:11
Xenon Reports Q4 and Full Year 2025 Financial Results and Provides Business Update
Finviz2026-02-26 21:06:42
Voyager Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
Finviz2026-03-09 20:06:47
Financial Data Highlights: Ovid Therapeutics Inc. (NASDAQ: OVID) reported in its latest financial statement that as of December 31, 2025, the company held a total of $90.4 million in cash, cash equivalents, and marketable securities.
老虎证券2026-03-18 10:23:26
Xenon Pharmaceuticals Shares Jump 20% Over Three Months: The Reasons Explained
101 finance2026-03-19 17:03:45
Neurocrine Biosciences: Upcoming 2027 Pipeline Results May Strengthen Its Competitive Edge—Is the Market Expecting Flawless Performance?
101 finance2026-03-22 17:27:39
Neurocrine Biosciences Presents First Expert Consensus Recommendations for Tardive Dyskinesia in Long-Term Care Settings
Finviz2026-03-26 12:31:08
Xenon Reports Q4 and Full Year 2025 Financial Results and Provides Business Update
Finviz2026-02-26 21:06:42
Voyager Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
Finviz2026-03-09 20:06:47
Financial Data Highlights: Ovid Therapeutics Inc. (NASDAQ: OVID) reported in its latest financial statement that as of December 31, 2025, the company held a total of $90.4 million in cash, cash equivalents, and marketable securities.
老虎证券2026-03-18 10:23:26
Xenon Pharmaceuticals Shares Jump 20% Over Three Months: The Reasons Explained
101 finance2026-03-19 17:03:45
Neurocrine Biosciences: Upcoming 2027 Pipeline Results May Strengthen Its Competitive Edge—Is the Market Expecting Flawless Performance?
101 finance2026-03-22 17:27:39
Neurocrine Biosciences Presents First Expert Consensus Recommendations for Tardive Dyskinesia in Long-Term Care Settings
Finviz2026-03-26 12:31:08
NBIX stock chart
NBIX stock detailsNBIX stock price change
On the last trading day, NBIX stock closed at 132.42 USD, with a price change of 0.98% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more